TREM2: A Potential Target for the Targeted Therapy of Metabolic Diseases
Metabolic diseases are characterized by profound dysregulation of the immunometabolic network, in which the interplay between chronic inflammation and metabolic disturbances form a self‐amplifying vicious cycle that drives disease progression. disease progression. Triggering receptor expressed on myeloid cells 2 (TREM2...